APA (7th ed.) Citation

Kondo, M., Suzuki, T., Kawano, Y., Kojima, S., Miyashiro, M., Matsumoto, A., . . . Distler, J. H. W. (2023). Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis. Friedrich-Alexander-Universität Erlangen-Nürnberg.

Chicago Style (17th ed.) Citation

Kondo, Masahiro, et al. Dersimelagon, a Novel Oral Melanocortin 1 Receptor Agonist, Demonstrates Disease-modifying Effects in Preclinical Models of Systemic Sclerosis. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2023.

MLA (9th ed.) Citation

Kondo, Masahiro, et al. Dersimelagon, a Novel Oral Melanocortin 1 Receptor Agonist, Demonstrates Disease-modifying Effects in Preclinical Models of Systemic Sclerosis. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2023.